Mark A. Glickman - 27 Jul 2023 Form 4 Insider Report for NeuroBo Pharmaceuticals, Inc. (NRBO)

Role
Director
Signature
/s/ Phillip D. Torrence, by Power of Attorney
Issuer symbol
NRBO
Transactions as of
27 Jul 2023
Transactions value $
$0
Form type
4
Filing time
28 Jul 2023, 06:11:20 UTC
Previous filing
12 May 2023
Next filing
07 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRBO Common Stock Award $0 +25K $0.00 25K 27 Jul 2023 Direct F1, F2
transaction NRBO Common Stock Award $0 +12.5K +50% $0.00 37.5K 27 Jul 2023 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units ("RSUs") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan.
F2 50% of the RSUs vested immediately, and the remainder will vest in two equal installments on each subsequent anniversary of the date of grant, subject to continuing service.
F3 Vests on the earlier of July 27, 2024 or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to continuing service.